Detalles de la búsqueda
1.
Perioperative Nivolumab in Resectable Lung Cancer.
N Engl J Med
; 390(19): 1756-1769, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38749033
2.
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design.
Future Oncol
; 17(12): 1459-1472, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33648347
3.
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Lancet
; 387(10026): 1415-1426, 2016 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26777916
4.
How Preconceptions About Lung Cancer Treatment Interact With Medical Discourse for Patients Who Accept Chemotherapy?
Psychooncology
; 26(6): 793-799, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27449209
5.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(6): 822-835, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27132212
6.
Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers.
J Neurosurg
; : 1-11, 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241682
7.
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
Lancet Oncol
; 13(3): 247-55, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22341744
8.
Brief Report: A Multidisciplinary Initial Workup for Suspected Lung Cancer as Fast-Track Intervention to Histopathologic Diagnosis.
JTO Clin Res Rep
; 4(6): 100526, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333015
9.
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
Clin Lung Cancer
; 24(1): 1-10, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180314
10.
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study.
JTO Clin Res Rep
; 2(11): 100234, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34746886
11.
Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.
Lung Cancer
; 143: 19-26, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32200137
12.
Development and Validation of a Simplified Prognostic Score in SCLC.
JTO Clin Res Rep
; 1(1): 100016, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589918
13.
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
Eur J Cancer
; 138: 193-201, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32898792
14.
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
JCI Insight
; 5(15)2020 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32759499
15.
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.
J Clin Med
; 9(12)2020 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33261056
16.
Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma.
J Clin Invest
; 130(2): 612-624, 2020 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31671073
17.
Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs.
Clin Cancer Res
; 25(14): 4280-4289, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936123
18.
Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial.
Cancers (Basel)
; 11(12)2019 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31766357
19.
An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer.
PLoS One
; 14(8): e0220988, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31430345
20.
A Randomized Non-Comparative Phase II Study of Anti-Programmed Cell Death-Ligand 1 Atezolizumab or Chemotherapy as Second-Line Therapy in Patients With Small Cell Lung Cancer: Results From the IFCT-1603 Trial.
J Thorac Oncol
; 14(5): 903-913, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30664989